The global COVID-19 pandemic brought to the forefront the critical importance of healthcare in ways not seen for generations. On the one hand, it underscored the vital role that the pharmaceutical industry and innovative medicines have to play in ensuring global safety and security. On the other hand, it also exposed vulnerabilities across the global economy, including in healthcare services.
Even as we move closer to the end of the COVID-19 pandemic, the impact on the pharmaceutical industry will be felt for decades to come. In this whitepaper, GlobalData’s life sciences experts identify the seven key trends that every pharma market access and planning professional needs to understand as the industry continues to evolve. Download the whitepaper today to learn more.
We offer advanced market analysis, in-depth market data, deeper visibility into IRP and risk assessment scoring to aid drug makers rethinking their pricing models and strategy.
Ready to enhance your 2022 strategy?
With the power of our market-leading drug pricing database, headline analysis updates, and the insights and analysis of our extensive local experts’ network, we’ll ensure you stay up-to-date on today’s market dynamics.